HPS5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.752300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.115560E-01
Normal-vs-Stage2
1.210810E-01
Normal-vs-Stage3
1.573350E-01
Normal-vs-Stage4
4.736800E-01
Stage1-vs-Stage2
7.027000E-01
Stage1-vs-Stage3
5.415600E-02
Stage1-vs-Stage4
5.134400E-01
Stage2-vs-Stage3
1.084650E-01
Stage2-vs-Stage4
6.981000E-01
Stage3-vs-Stage4
1.352400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.872100E-02
Normal-vs-AfricanAmerican
4.432600E-01
Normal-vs-Asian
1.123000E-01
Caucasian-vs-AfricanAmerican
5.373600E-01
Caucasian-vs-Asian
7.388600E-01
AfricanAmerican-vs-Asian
5.192200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.288300E-02
Normal-vs-Female
1.114550E-01
Male-vs-Female
2.734200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.454600E-01
Normal-vs-Age(41-60Yrs)
2.853400E-01
Normal-vs-Age(61-80Yrs)
4.791600E-02
Normal-vs-Age(81-100Yrs)
8.462400E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.119400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.632000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.724400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.115200E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.371810E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.812200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.512000E-02
Normal-vs-Daily Drinker
1.223760E-02
Normal-vs-Weekly Drinker
1.234840E-01
Normal-vs-Occasional Drinker
3.053400E-01
Normal-vs-Social Drinker
4.295400E-01
Non Drinker-vs-Daily Drinker
4.401800E-01
Non Drinker-vs-Weekly Drinker
4.490600E-01
Non Drinker-vs-Occasional Drinker
4.616000E-02
Non Drinker-vs-Social Drinker
1.902410E-02
Daily Drinker-vs-Weekly Drinker
2.116600E-01
Daily Drinker-vs-Occasional Drinker
1.986000E-02
Daily Drinker-vs-Social Drinker
9.204600E-03
Weekly Drinker-vs-Occasional Drinker
3.596200E-01
Weekly Drinker-vs-Social Drinker
2.223000E-01
Occasional Drinker-vs-Social Drinker
7.099600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.669000E-01
Normal-vs-Grade 2
1.222750E-01
Normal-vs-Grade 3
1.391790E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.274380E-02
Grade 1-vs-Grade 3
2.463800E-02
Grade 1-vs-Grade 4
4.669000E-01
Grade 2-vs-Grade 3
8.981400E-01
Grade 2-vs-Grade 4
1.222750E-01
Grade 3-vs-Grade 4
1.391790E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.327900E-02
Normal-vs-NonDiabetic
5.168000E-02
Diabetic-vs-NonDiabetic
7.559000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.473580E-01
Normal-vs-NoPancreatitis
6.227800E-02
Pancreatitis-vs-NoPancreatitis
9.401600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.081220E-01
Normal-vs-N1
9.639500E-02
N0-vs-N1
8.762200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.146160E-01
Normal-vs-TP53-NonMutant
1.605440E-01
TP53-Mutant-vs-TP53-NonMutant
7.959200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
